Date | Time | Source | Headline | Symbol | Company |
09/27/2012 | 4:22PM | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:GNOM | Global X Genomics and Biotechnology |
09/25/2012 | 3:54PM | Edgar (US Regulatory) | Statement of Ownership: Solicitation (SC 14D9) | NASDAQ:GNOM | Global X Genomics and Biotechnology |
09/25/2012 | 2:42PM | Edgar (US Regulatory) | Statement of Beneficial Ownership (SC 13D) | NASDAQ:GNOM | Global X Genomics and Biotechnology |
09/25/2012 | 2:37PM | Edgar (US Regulatory) | Tender offer statement by Third Party (SC TO-T) | NASDAQ:GNOM | Global X Genomics and Biotechnology |
09/25/2012 | 8:00AM | PR Newswire (US) | BGI-Shenzhen Begins Tender Offer to Acquire Complete Genomics, inc. | NASDAQ:GNOM | Global X Genomics and Biotechnology |
09/20/2012 | 5:28PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:GNOM | Global X Genomics and Biotechnology |
09/19/2012 | 12:07PM | Business Wire | SHAREHOLDER ALERT: Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the ... | NASDAQ:GNOM | Global X Genomics and Biotechnology |
09/18/2012 | 9:30PM | PR Newswire (US) | Law Office of Brodsky & Smith, LLC Announces Investigation of Complete Genomics, Inc. | NASDAQ:GNOM | Global X Genomics and Biotechnology |
09/18/2012 | 3:26PM | Business Wire | Rigrodsky & Long, P.A. Announces Investigation Of Complete Genomics, Inc. Buyout | NASDAQ:GNOM | Global X Genomics and Biotechnology |
09/18/2012 | 11:03AM | PR Newswire (US) | Harwood Feffer LLP Announces Investigation of Complete Gnomics, Inc. | NASDAQ:GNOM | Global X Genomics and Biotechnology |
09/18/2012 | 10:34AM | Business Wire | Ryan & Maniskas, LLP Announces Investigation of Complete Genomics, Inc. | NASDAQ:GNOM | Global X Genomics and Biotechnology |
09/17/2012 | 6:00PM | Business Wire | Complete Genomics Inc. Board of Directors Under Investigation for Potential Breaches of Fiduciary Duty by Glancy Binkow & Gol... | NASDAQ:GNOM | Global X Genomics and Biotechnology |
09/17/2012 | 5:16PM | Edgar (US Regulatory) | Written communication by the subject company relating to a third party tender offer (SC14D9C) | NASDAQ:GNOM | Global X Genomics and Biotechnology |
09/17/2012 | 5:14PM | Edgar (US Regulatory) | Written communication relating to an issuer or third party (SC TO-C) | NASDAQ:GNOM | Global X Genomics and Biotechnology |
09/17/2012 | 3:32PM | Business Wire | Faruqi & Faruqi, LLP is Seeking More Cash for the Shareholders of Complete Genomics, Inc. (GNOM) | NASDAQ:GNOM | Global X Genomics and Biotechnology |
09/17/2012 | 3:25PM | Business Wire | Complete Genomics Shareholder Alert: The Briscoe Law Firm and Powers Taylor, LLP Investigate Sale to BGI-Shenzhen | NASDAQ:GNOM | Global X Genomics and Biotechnology |
09/17/2012 | 2:57PM | Business Wire | Pomerantz Law Firm Investigates Claims on Behalf of Investors of Complete Genomics, Inc. | NASDAQ:GNOM | Global X Genomics and Biotechnology |
09/17/2012 | 2:41PM | Business Wire | Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Complete Genomics, Inc. | NASDAQ:GNOM | Global X Genomics and Biotechnology |
09/17/2012 | 1:34PM | Business Wire | Newman Ferrara LLP Announces Investigation of Complete Genomics, Inc. | NASDAQ:GNOM | Global X Genomics and Biotechnology |
09/17/2012 | 1:00PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GNOM | Global X Genomics and Biotechnology |
09/17/2012 | 10:03AM | Business Wire | Rigrodsky & Long, P.A. Announces Investigation Of Complete Genomics, Inc. Buyout | NASDAQ:GNOM | Global X Genomics and Biotechnology |
09/17/2012 | 9:19AM | Dow Jones News | U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH | NASDAQ:GNOM | Global X Genomics and Biotechnology |
09/17/2012 | 6:30AM | GlobeNewswire Inc. | Complete Genomics and BGI-Shenzhen Announce Definitive Agreement to Merge | NASDAQ:GNOM | Global X Genomics and Biotechnology |
09/12/2012 | 8:20AM | Marketwired | Biotech Industry Looks to Benefit From New Legislation Passed to Help Speed Up FDA Review Process | NASDAQ:GNOM | Global X Genomics and Biotechnology |
09/06/2012 | 4:31PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GNOM | Global X Genomics and Biotechnology |
08/27/2012 | 8:20AM | Marketwired | Biotech Industry Merger and Acquisition Activity at a Four-Year High | NASDAQ:GNOM | Global X Genomics and Biotechnology |
08/13/2012 | 8:20AM | Marketwired | Biotechnology Industry Continues to Show Investors Strong Gains in 2012 -- Complete Genomics Soars on Strong Results | NASDAQ:GNOM | Global X Genomics and Biotechnology |
08/09/2012 | 5:11PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:GNOM | Global X Genomics and Biotechnology |
08/09/2012 | 6:03AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GNOM | Global X Genomics and Biotechnology |
08/08/2012 | 4:01PM | GlobeNewswire Inc. | Complete Genomics Reports Second Quarter 2012 Results | NASDAQ:GNOM | Global X Genomics and Biotechnology |